Selected article for: "acute respiratory and loop structure"
Author: Madu, Ikenna G.; Belouzard, Sandrine; Whittaker, Gary R.
Title: SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion
  • Cord-id: i4e5jq7a
  • Document date: 2009_10_25
    • ID: i4e5jq7a
    Snippet: Abstract The S2 domain of the coronavirus spike (S) protein is known to be responsible for mediating membrane fusion. In addition to a well-recognized cleavage site at the S1–S2 boundary, a second proteolytic cleavage site has been identified in the severe acute respiratory syndrome coronavirus (SARS-CoV) S2 domain (R797). C-terminal to this S2 cleavage site is a conserved region flanked by cysteine residues C822 and C833. Here, we investigated the importance of this well conserved region for
    Document: Abstract The S2 domain of the coronavirus spike (S) protein is known to be responsible for mediating membrane fusion. In addition to a well-recognized cleavage site at the S1–S2 boundary, a second proteolytic cleavage site has been identified in the severe acute respiratory syndrome coronavirus (SARS-CoV) S2 domain (R797). C-terminal to this S2 cleavage site is a conserved region flanked by cysteine residues C822 and C833. Here, we investigated the importance of this well conserved region for SARS-CoV S-mediated fusion activation. We show that the residues between C822–C833 are well conserved across all coronaviruses. Mutagenic analysis of SARS-CoV S, combined with cell–cell fusion and pseudotyped virion infectivity assays, showed a critical role for the core-conserved residues C822, D830, L831, and C833. Based on available predictive models, we propose that the conserved domain flanked by cysteines 822 and 833 forms a loop structure that interacts with components of the SARS-CoV S trimer to control the activation of membrane fusion.

    Search related documents:
    Co phrase search for related documents
    • acute sars cov respiratory syndrome coronavirus and low ph receptor binding: 1, 2
    • acute sars cov respiratory syndrome coronavirus and luciferase 100: 1
    • acute sars cov respiratory syndrome coronavirus and luciferase activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute sars cov respiratory syndrome coronavirus and luciferase activity assay: 1, 2, 3
    • acute sars cov respiratory syndrome coronavirus and luciferase gene: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute sars cov respiratory syndrome coronavirus and lysis buffer: 1, 2, 3
    • loading buffer and luciferase 100: 1
    • loading buffer and luciferase activity: 1
    • loading buffer and luciferase gene: 1
    • loading buffer and lysate affinity: 1
    • loading buffer and lysis buffer: 1, 2, 3, 4, 5, 6
    • loop region and luciferase gene: 1
    • luciferase 100 and lysis buffer: 1, 2, 3
    • luciferase activity and lysis buffer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • luciferase activity assay and lysis buffer: 1, 2, 3
    • luciferase gene and lysis buffer: 1, 2
    • luciferase promega assay kit and lysis buffer: 1, 2
    • lysate affinity and lysis buffer: 1